Keith Bowering (K Bowering)

Publication Activity (10 Years)

Years Active: 2017-2018
Publications (10 Years): 5

Top Topics

Placebo Controlled

Glycemic Control

Cardiovascular Disease

Top Venues

Diabetic medicine : a journal of the British Diabetic Association

Diabetes therapy : research, treatment and education of diabetes and related disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Keith Bowering, Helena W Rodbard, David Russell-Jones, Bruce Bode, Stewart Harris, Milivoj Piletic, Simon Heller, Vincent Woo, Vinay Babu, Claus Dethlefsen, Chantal Mathieu
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 10 (1) (2018)
Bruce W Bode, Keith Bowering, David L Russell-Jones
Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957. Diabetes care 41 (3) (2018)
Simon R Heller, Keith Bowering, P Raskin, A Liebl, K Buchholtz, A Gorst-Rasmussen, T R Pieber
The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis. Diabetic medicine : a journal of the British Diabetic Association (2018)
Keith Bowering, J Harvey, J W Kolaczynski, J W Snyder, B W Bode
Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association 36 (6) (2018)
Keith Bowering, Christopher Case, John Harvey, Michael Reeves, Michael Sampson, Robert Strzinek, Ditte-Marie Bretler, Rikke Beck Bang, Bruce W Bode
Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial. Diabetes care 40 (7) (2017)